Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Clinical Applications of Epidermal Stem Cells01:19

Clinical Applications of Epidermal Stem Cells

2.4K
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
2.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Benchmarking reliability and calibration of LLMs for multi-cancer early detection test communication.

JAMIA open·2026
Same author

TMK1-mediated phosphorylation and destabilization of DA1 connects auxin signaling with seed size control in Arabidopsis.

Molecular plant·2026
Same author

SDGD-YOLO: a lightweight detection model for assessing the ripeness of black raspberries in complex greenhouse environments.

Frontiers in plant science·2026
Same author

A nurse-led foot care educational intervention for adults with end-stage kidney disease on haemodialysis: A pilot quantitative study.

Journal of tissue viability·2026
Same author

An Interpretable Multimodal Architecture for the Discovery of High-Efficiency Thermally Activated Delayed Fluorescence Emitters.

ACS nano·2026
Same author

Ciltacabtagene autoleucel in high-risk smoldering multiple myeloma: the CAR-PRISM phase 2 trial.

Nature medicine·2026

Related Experiment Video

Updated: May 2, 2026

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells
08:46

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells

Published on: November 12, 2019

53.5K

The Clinical Utility of Real-Time Patient-Reported Outcomes in Cell Therapy Recipients.

Kenneth R Meehan1, Julie Doherty2, Joel King2

  • 1Transplant and Cellular Therapy Program, Section of Hematology, Dartmouth-Hitchcock Medical Center, The Dartmouth Cancer Center, Lebanon, New Hampshire.

Transplantation and Cellular Therapy
|September 5, 2025
PubMed
Summary

Real-time patient-reported outcome measures (PROMs) and agenda-setting questions in an electronic dashboard improve communication and decision-making for cellular therapy patients, benefiting both patients and clinicians.

Keywords:
Agenda-settingElectronic health recordsHematopoietic stem cell transplantationPatient-centered carePatient-clinician relationship: surveys and questionnairesPatient-reported outcome measuresPrevisit planningShared decision-making

More Related Videos

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

4.5K
Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography
09:34

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Published on: February 17, 2022

3.5K

Related Experiment Videos

Last Updated: May 2, 2026

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells
08:46

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells

Published on: November 12, 2019

53.5K
Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

4.5K
Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography
09:34

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Published on: February 17, 2022

3.5K

Area of Science:

  • Oncology
  • Hematology
  • Health Informatics

Background:

  • Patient-reported outcome measures (PROMs) enhance patient care by mitigating treatment toxicities and supporting shared decision-making.
  • Integrating PROMs can identify unmet patient needs and improve clinical outcomes.

Purpose of the Study:

  • To assess the feasibility and utility of real-time, electronically captured agenda-setting questions and PROMs during clinic visits.
  • To evaluate the impact of a clinical decision support dashboard on patient-clinician communication.

Main Methods:

  • Prospective observational study utilizing a pre-visit questionnaire (PVQ) with agenda-setting questions and PROMIS-29 survey.
  • Results were integrated into an electronic medical record (EMR) clinical decision support dashboard for real-time use.
  • Study included 237 cellular therapy recipients (allogeneic, autologous, CAR-T) from April 2022 to January 2025.

Main Results:

  • PVQ completion rates averaged 60% weekly, reaching 80% over the study period.
  • 82% of patients felt the dashboard improved discussions with clinicians, and 78% reported better healthcare decision-making.
  • 91% of patients and 89% of clinicians found the dashboard aided shared decision-making.

Conclusions:

  • Real-time PROMs and agenda-setting questions via an electronic dashboard are feasible and useful for cellular therapy patients.
  • The dashboard significantly improved patient-clinician communication and shared decision-making.
  • This approach offers advantages for both patients and clinicians in managing cellular therapy.